NervGen Pharma Corp. Stock Forecast
Explanation to Bollinger's Bands
Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.
Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.
Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation
BandWidth defines the current width of the band.
%b defines the current position within the band.
BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)
Live Samples:
Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.
Source: http://www.bollingerbands.com
NervGen Pharma Corp. stock price down 1.74% on Friday
(Updated on Jun 14, 2024)
The NervGen Pharma Corp. stock price fell by -1.74% on the last day (Friday, 14th Jun 2024) from $1.72 to $1.69. During the last trading day the stock fluctuated 2.96% from a day low at $1.69 to a day high of $1.74. The price has been going up and down for this period, and there has been a 18.18% gain for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -42 thousand shares and in total, 15 thousand shares were bought and sold for approximately $25.69 thousand.
The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $1.74 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -9.82% during the next 3 months and, with a 90% probability hold a price between $1.15 and $1.57 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
NGENF Signals & Forecast
The NervGen Pharma Corp. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $1.62 and $1.53. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, June 12, 2024, and so far it has fallen -3.43%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss for NervGen Pharma Corp. stock
NervGen Pharma Corp. finds support from accumulated volume at $1.67 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0500 between high and low, or 2.96%. For the last week the stock has had daily average volatility of 7.34%.
Our recommended stop-loss: $1.61 (-4.63%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 7 days ago.)
Trading Expectations (NGENF) For The Upcoming Trading Day Of Monday 17th
For the upcoming trading day on Monday, 17th we expect NervGen Pharma Corp. to open at $1.71, and during the day (based on 14 day Average True Range), to move between $1.59 and $1.79, which gives a possible trading interval of +/-$0.104 (+/-6.16%) up or down from last closing price. If NervGen Pharma Corp. takes out the full calculated possible swing range there will be an estimated 12.32% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $1.70 (0.59%) than the support at $1.67 (1.18%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is NervGen Pharma Corp. stock A Buy?
NervGen Pharma Corp. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
Current score: 0.806 Hold/Accumulate Unchanged
Predicted Opening Price for NervGen Pharma Corp. of Monday, June 17, 2024
| Fair opening price June 17, 2024 | Current price |
|---|---|
| $1.71 ( 0.99%) | $1.69 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for NGENF
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 1.76 | 3.94% |
| R2 | 1.74 | 2.81% |
| R1 | 1.73 | 2.12% |
| Price | 1.69 | |
| S1 | 1.69 | -0.144% |
| S2 | 1.68 | -0.84% |
| S3 | 1.66 | -1.97% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 1.82 | 7.51% |
| R2 | 1.79 | 5.92% |
| R1 | 1.70 | 0.592% |
| Price | 1.69 | |
| S1 | 1.67 | -1.18% |
| S2 | 1.61 | -4.73% |
| S3 | 1.53 | -9.47% |
FAQ
Click here for our free guide on how to buy NervGen Pharma Corp. Stock.
